<DOC>
	<DOCNO>NCT01995760</DOCNO>
	<brief_summary>The purpose study evaluate appropriate parameter correlate clinical effectiveness vancomycin : trough drug level AUC/MIC .</brief_summary>
	<brief_title>The Most Appropriate Parameter Correlates With Clinical Effectiveness Vancomycin : Trough Drug Concentration Area Under Curve ( AUC ) /Minimum Inhibitory Concentration ( MIC ) ?</brief_title>
	<detailed_description>Several study show AUC/MIC well pharmacokinetic-pharmacodynamic parameter clinical effectiveness vancomycin . However , 2009 consensus guideline vancomycin therapeutic monitoring continue recommend trough serum concentration monitor clinical setting . In 2011 , Patel et al show highly difference AUC ( 72-96h ) Cmin ( 96h ) . Different dose creatinine clearance may reach trough drug level different AUC . The investigator wonder whether trough drug level serve substitute marker AUC parameter vancomycin therapeutic monitoring . In study , investigator calculate AUC/MIC vancomycin publish formula , analyze correlation patient 's clinical outcome compare trough drug level .</detailed_description>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Inpatients National Taiwan University Hospital Age equal 20 year old Positive methicillinresistant Staphylococcus aureus blood culture Receiving vancomycin therapy definitive use Undergoing therapeutic drug monitoring ( serum vancomycin concentration level ) Age 20 year old Without detail vancomycin dose frequency Vancomycin treatment shorter 72 hour Without renal function data ( serum creatinine level , creatinine clearance ) Without infectionrelated clinical outcome ( lab data white blood cell count , seg , C reactive protein , body temperature record ) Receiving renal replacement therapy Therapeutic drug monitoring reach steady state With abnormal undefined serum concentration</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>vancomycin</keyword>
	<keyword>therapeutic response monitoring</keyword>
	<keyword>AUC/MIC</keyword>
</DOC>